We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

83 hedge funds and large institutions have $390M invested in Oxford Immunotec Global PLC Ordinary Shares in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

52% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 23

42% more capital invested

Capital invested by funds: $275M → $390M (+$114M)

8% more funds holding

Funds holding: 77 → 83 (+6)

Holders
83
Holders Change
+6
Holders Change %
+7.79%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
15
Increased
35
Reduced
23
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
+$5.06M
2
GIM
Granahan Investment Management
Massachusetts
+$4M
3
SCM
Stonepine Capital Management
Oregon
+$3.23M
4
EIM
Essex Investment Management
Massachusetts
+$2.45M
5
ECM
Endurant Capital Management
California
+$1.98M

Top Sellers

Rank Fund Capital Flow
1
Axa
Axa
France
-$6.19M
2
NLVP
New Leaf Venture Partners
New York
-$4.02M
3
Invesco
Invesco
Georgia
-$3.96M
4
DM
Deerfield Management
New York
-$3.2M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$1.78M +$541K +37,829 +53%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$1.75M -$152K -10,649 -9%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.69M -$769K -53,803 -34%
Renaissance Technologies
29
Renaissance Technologies
New York
$1.68M +$1.18M +82,242 +391%
BC
30
Birchview Capital
Vermont
$1.63M -$815K -57,000 -36%
TIM
31
Triodos Investment Management
Netherlands
$1.62M – – –
KCM
32
Kennedy Capital Management
Missouri
$1.58M -$735K -51,415 -35%
Vanguard Group
33
Vanguard Group
Pennsylvania
$1.55M +$26.3K +1,839 +2%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$1.43M +$123K +8,606 +11%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$1.41M -$151K -10,590 -11%
Citadel Advisors
36
Citadel Advisors
Florida
$1.38M +$70.2K +4,911 +6%
OAM
37
Oxford Asset Management
United Kingdom
$1.34M -$481K -33,637 -29%
KCM
38
Kornitzer Capital Management
Kansas
$1.31M – – –
Marshall Wace
39
Marshall Wace
United Kingdom
$1.3M +$1.15M +80,435 New
JP Morgan Chase
40
JP Morgan Chase
New York
$1.3M +$213K +14,904 +23%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$1.3M +$1.14M +80,000 New
BA
42
Boston Advisors
Massachusetts
$1.29M +$1.13M +79,256 New
SIM
43
Spark Investment Management
New York
$1.24M -$971K -67,900 -47%
TA
44
Teachers Advisors
New York
$1.21M -$12.7K -889 -1%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$1.2M +$230K +16,100 +28%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.14M +$7.35K +514 +0.7%
Millennium Management
47
Millennium Management
New York
$881K +$537K +37,563 +224%
Bank of America
48
Bank of America
North Carolina
$847K +$27.4K +1,917 +4%
Fidelity Investments
49
Fidelity Investments
Massachusetts
$812K +$715K +50,000 New
Charles Schwab
50
Charles Schwab
California
$775K – – –
1
2
3 4

OXFD Hedge Fund Activity: Q3 2018 in Review

83 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2018, worth a combined $390M — up 42% from $275M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new OXFD positions and 9 closed out — a net gain of 6 holders — while 35 added to existing stakes and 23 trimmed.

The largest buyer was First Light Asset Management, adding an estimated $5.06M. The largest seller was Axa, exiting entirely with an estimated $6.19M sold.

  • 83 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2018, up from 77 in Q2 2018.
  • Funds reported $390M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2018, up 42% quarter-over-quarter.
  • 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2018 and 9 closed out, a net change of +6 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2018 was First Light Asset Management, an estimated $5.06M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2018 was Axa, an estimated $6.19M sold.

Based on aggregated 13F filings for Q3 2018.